UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Forestar Group
FOR
$1.51B
| $759K | ﹤0.01% |
28,178
+15,154
| +116% | +$418K |
|
|
NNDM
4327
Nano Dimension
NNDM
$348M
| $759K | ﹤0.01% |
279,035
-51,893
| -16% | -$151K |
|
4328
Greystone Housing Impact Investors LP
GHI
$144M
| $759K | ﹤0.01% |
49,523
-8,343
| -14% | -$132K |
|
4329
National Healthcare
NHC
$3.44B
| $758K | ﹤0.01% |
11,855
+1,002
| +9% | +$64.2K |
|
|
EDD
4330
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$374M
| $758K | ﹤0.01% |
177,868
+4,140
| +2% | +$19.4K |
|
|
RFI
4331
Cohen & Steers Total Return Realty Fund
RFI
$309M
| $756K | ﹤0.01% |
72,096
-3,653
| -5% | -$41.3K |
|
|
FINV
4332
FinVolution Group
FINV
$1.07B
| $756K | ﹤0.01% |
151,715
-200,129
| -57% | -$1.05M |
|
4333
LegalZoom.com
LZ
$993M
| $754K | ﹤0.01% |
68,964
-12,130
| -15% | -$149K |
|
|
CCF
4334
DELISTED
Chase Corporation
CCF
| $754K | ﹤0.01% |
5,926
-254
| -4% | -$31.8K |
|
|
BPMC
4335
PUT
DELISTED
Blueprint Medicines
BPMC
| $753K | ﹤0.01% |
15,000
| – | – |
|
4336
ReposiTrak
TRAK
$158M
| $752K | ﹤0.01% |
85,860
+10,960
| +15% | +$101K |
|
4337
WisdomTree Dynamic International Equity Fund
DDWM
$1.51B
| $751K | ﹤0.01% |
24,671
+16,558
| +204% | +$515K |
|
4338
Kura Oncology
KURA
$896M
| $751K | ﹤0.01% |
82,345
+82,328
| +484,282% | +$836K |
|
4339
Phreesia
PHR
$780M
| $749K | ﹤0.01% |
40,091
-6,358
| -14% | -$171K |
|
4340
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$461M
| $748K | ﹤0.01% |
27,568
+5,141
| +23% | +$146K |
|
4341
Wabash National
WNC
$509M
| $748K | ﹤0.01% |
35,404
-18,167
| -34% | -$418K |
|
4342
QCR Holdings
QCRH
$1.75B
| $747K | ﹤0.01% |
15,401
+4,822
| +46% | +$239K |
|
4343
GrafTech
EAF
$203M
| $747K | ﹤0.01% |
19,508
+7,081
| +57% | +$296K |
|
|
WTPI
4344
WisdomTree Equity Premium Income Fund
WTPI
$504M
| $747K | ﹤0.01% |
24,308
-17,047
| -41% | -$547K |
|
4345
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$96.8M
| $747K | ﹤0.01% |
37,467
-1,704
| -4% | -$34.7K |
|
4346
TTM Technologies
TTMI
$14.6B
| $746K | ﹤0.01% |
57,920
-24,836
| -30% | -$346K |
|
|
PCK
4347
DELISTED
Pimco California Municipal Income Fund II
PCK
| $742K | ﹤0.01% |
147,897
-17,164
| -10% | -$97.9K |
|
|
PEO
4348
Adams Natural Resources Fund
PEO
$772M
| $741K | ﹤0.01% |
33,326
+2,701
| +9% | +$58.5K |
|
|
DCPH
4349
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $741K | ﹤0.01% |
58,259
-31,133
| -35% | -$430K |
|
|
AGEN
4350
Agenus
AGEN
$315M
| $741K | ﹤0.01% |
32,787
-11,236
| -26% | -$319K |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.